(The Center Square) – An additional nine of the world’s largest pharmaceutical companies have agreed to offer many of their most popular drugs at most-favored-nation pricing in the U.S.
This means that the U.S. will pay the lowest price for many prescription drugs among its economic peers. The initiative has been a major priority for President Donald Trump, according to top Health and Human Services officials, as he has sought to reduce prescription drug prices for Americans.
“We got a lot of calls from the president, and at one point in this negotiation, we just stopped answering our phones late at night because we couldn’t take it anymore,” said HHS Secretary Robert F. Kennedy, Jr.
The nine companies that joined the president and others from…




